[{"NetIncomeLoss_1_Q3_USD":-53495000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":71479.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":73466.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":62696000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":46591000.0,"InventoryFinishedGoods_0_Q3_USD":445000.0,"OperatingCostsAndExpenses_3_Q3_USD":1653000.0,"OperatingCostsAndExpenses_1_Q3_USD":438000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":603000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":718000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-85082000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":161802000.0,"AssetsCurrent_0_Q3_USD":285447000.0,"DepreciationAndAmortization_3_Q3_USD":715000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":247911000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":30967000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":6313000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1241000.0,"AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear_0_Q3_Security":27.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":162855000.0,"CommonStockSharesIssued_0_Q3_shares":73528000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":220114000.0,"Assets_0_Q3_USD":337587000.0,"ShareBasedCompensation_3_Q3_USD":18093000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":9694000.0,"DeferredRevenue_0_Q3_USD":297000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":92488000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ConvertibleLongTermNotesPayable_0_Q3_USD":115802000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":113628000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":37037000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":33000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-15000.0,"AssetsFairValueDisclosure_0_Q3_USD":258667000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-177000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-141000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":247000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":44000.0,"CommonStockValue_0_Q3_USD":7000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":39371000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":33000.0,"EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_0_Q3_USD":2300000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":168115000.0,"IncreaseDecreaseInInventories_3_Q3_USD":1665000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-152212000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-53783000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1437000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":82301000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":11797000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1109350000.0,"Liabilities_0_Q3_USD":253817000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":6313000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":640000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-319000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":219482000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":33000.0,"ConvertibleDebtFairValueDisclosures_0_Q3_USD":104700000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":953000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1026190000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-46582000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":3200000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":172500000.0,"CommonStockSharesOutstanding_0_Q3_shares":73528000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-152605000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-53451000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":18093000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6513000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":31000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-129600000.0,"LiabilitiesCurrent_0_Q3_USD":52630000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":5945000.0,"DeferredRevenueCurrent_0_Q3_USD":297000.0,"NonoperatingIncomeExpense_3_Q3_USD":-17821000.0,"NonoperatingIncomeExpense_1_Q3_USD":-6342000.0,"InterestExpense_3_Q3_USD":20068000.0,"InterestExpense_1_Q3_USD":6801000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":84107000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8242000.0,"PaymentsForRoyalties_3_Q3_USD":4521000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":62696000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"ReceivablesNetCurrent_0_Q3_USD":11062000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2357000.0,"NetIncomeLoss_3_Q3_USD":-152852000.0,"AccountsPayableCurrent_0_Q3_USD":2422000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-710000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":26000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":72985000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":21333000.0,"OperatingIncomeLoss_3_Q3_USD":-134784000.0,"OperatingIncomeLoss_1_Q3_USD":-47109000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":180743000.0,"InventoryNet_0_Q3_USD":2011000.0,"DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_3_Q3_USD":0.0,"InvestmentIncomeInterest_3_Q3_USD":2424000.0,"InvestmentIncomeInterest_1_Q3_USD":600000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":665000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":337587000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q3_USD":1566000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":18093000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6513000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1847000.0,"OperatingExpenses_3_Q3_USD":207769000.0,"OperatingExpenses_1_Q3_USD":68442000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":6686000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1088000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.14,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.73,"ProfitLoss_3_Q3_USD":-152852000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_3_Q3_USD":0.0,"OtherLiabilitiesCurrent_0_Q3_USD":1473000.0,"StockholdersEquity_0_Q3_USD":83770000.0,"DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_0_Q3_USD":67900000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-4236000.0,"Ticker":"KPTI","CIK":"1503802","name":"KARYOPHARM THERAPEUTICS INC.","OfficialName":"Karyopharm Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"566245834.0","Country":"United States","Sector":"Miscellaneous","Industry":"Diversified Commercial Services","Market":"NASDAQ","SP500":"nan","filed":"20201102"}]